日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Enhancing the Anticancer Activity of a Carcinoma-Directed Peptide-HLA-I Fusion Protein by Armoring with Mutein IFNα.

通过突变体 IFNα 增强癌靶向肽-HLA-I 融合蛋白的抗癌活性

Samplonius Douwe Freerk, van Wijngaarden Anne Paulien, Koll Lisanne, Ke Xiurong, Helfrich Wijnand

CD19-ReTARG(TPR): A Novel Fusion Protein for Physiological Engagement of Anti-CMV Cytotoxic T Cells Against CD19-Expressing Malignancies.

CD19-ReTARG(TPR):一种新型融合蛋白,可使抗CMV细胞毒性T细胞生理性地对抗表达CD19的恶性肿瘤

van Wijngaarden Anne Paulien, Britsch Isabel, Peipp Matthias, Samplonius Douwe Freerk, Helfrich Wijnand